Suchergebnisse - "McDonald, Kerrie L"

PubPharm (4)

1

A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma : the VERTU study

enthalten in: Neuro-oncology | 2021

von Sim, H. | McDonald, K. | Lwin, Z. | +15

2

Most clinical anti-EGFR antibodies do not neutralize both wtEGFR and EGFRvIII activation in glioma

enthalten in: Neuro-oncology | 2019

von Greenall, S. | McKenzie, M. | Seminova, E. | +10

3

Glioma through the looking GLASS : molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium

enthalten in: Neuro-oncology | 2018

von GLASS Consortium | Aldape, K. | Amin, S. | +54

4

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

enthalten in: Neuro-oncology | 2015

von Rapkins, R. | Wang, F. | Nguyen, H. | +6

1
[1]